FDA Likely to Approve Pfizer Booster Shots — Even if They Don’t Work — Thanks to Outdated Rules Favoring Drug Companies

In today’s pharmaceutical universe, a simple “safe and effective” standard can be manipulated to sell drugs of questionable value. There’s also big money involved: Pfizer is already projecting $26 billion in COVID revenue this year.